<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54">
 <label>54.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bernstein</surname>
    <given-names>DI</given-names>
   </name>
   <name>
    <surname>Atmar</surname>
    <given-names>RL</given-names>
   </name>
   <name>
    <surname>Lyon</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Treanor</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>WH</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>X</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults</article-title>. 
  <source>J Infect Dis.</source> (
  <year>2015</year>) 
  <volume>211</volume>:
  <fpage>870</fpage>â€“
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiu497</pub-id>
  <?supplied-pmid 25210140?>
  <pub-id pub-id-type="pmid">25210140</pub-id>
 </mixed-citation>
</ref>
